BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND CARS, P49589, 833, ENSG00000110619
93 results:

  • 1. Chimeric Antigen Receptor T Cell Therapy for pancreatic cancer: A Review of Current Evidence.
    Czaplicka A; Lachota M; Pączek L; Zagożdżon R; Kaleta B
    Cells; 2024 Jan; 13(1):. PubMed ID: 38201305
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Insights from managing clinical issues in distal pancreatectomy with en bloc coeliac axis resection: experiences from 626 patients.
    Nakamura T; Okada KI; Ohtsuka M; Higuchi R; Takahashi H; Nagai K; Unno M; Murakami Y; Oba A; Tomikawa M; Kato A; Horiguchi A; Nakamura M; Yagi S; Satoi S; Endo I; Amano R; Matsumoto I; Ito YM; Nagakawa T; Hirano S
    Br J Surg; 2023 Sep; 110(10):1387-1394. PubMed ID: 37469172
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Genetic counselling referral practices for patients with pancreatic adenocarcinoma: A French retrospective multicentre observational cohort study (CAPANCOGEN).
    Brugel M; Marulier T; Evrard C; Carlier C; Tougeron D; Piessen G; Truant S; Turpin A; Williet N; Botsen D; Brasseur M; Perrier M; Bouché O
    Pancreatology; 2023 Sep; 23(6):622-629. PubMed ID: 37394294
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. pancreatic neuroendocrine tumor: prediction of tumor grades by radiomics models based on ultrasound images.
    Dong Y; Yang DH; Tian XF; Lou WH; Wang HZ; Chen S; Qiu YJ; Wang W; Dietrich CF
    Br J Radiol; 2023 Sep; 96(1149):20220783. PubMed ID: 37393539
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. pancreatic adverse events of immune checkpoint inhibitors therapy for solid cancer patients: a systematic review and meta-analysis.
    Zhao Z; Zhang W; Pang L; Zeng L; Liu S; Liu J
    Front Immunol; 2023; 14():1166299. PubMed ID: 37359551
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey.
    Reni M; Giommoni E; Bergamo F; Milella M; Cavanna L; Di Marco MC; Spada M; Cordio S; Aprile G; Cardellino GG; Maiello E; Bernardini I; Ghidini M; Bozzarelli S; Macchini M; Orsi G; De Simone I; Rulli E; Porcu L; Torri V; Pinto C;
    ESMO Open; 2023 Feb; 8(1):100777. PubMed ID: 36731325
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Novel banana lectin CAR-T cells to target pancreatic tumors and tumor-associated stroma.
    McKenna MK; Ozcan A; Brenner D; Watanabe N; Legendre M; Thomas DG; Ashwood C; Cummings RD; Bonifant C; Markovitz DM; Brenner MK
    J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36653070
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Establishment of the diagnostic and prognostic nomograms for pancreatic cancer with bone metastasis.
    Liu Z; Liu H; Wang D
    Sci Rep; 2022 Oct; 12(1):18085. PubMed ID: 36302941
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Association of dipeptidyl peptidase-4 inhibitor use and risk of pancreatic cancer in individuals with diabetes in Japan.
    Kubota S; Haraguchi T; Kuwata H; Seino Y; Murotani K; Tajima T; Terashima G; Kaneko M; Takahashi Y; Takao K; Kato T; Shide K; Imai S; Suzuki A; Terauchi Y; Yamada Y; Seino Y; Yabe D
    J Diabetes Investig; 2023 Jan; 14(1):67-74. PubMed ID: 36281720
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Risk factors for hepatocellular carcinoma at baseline and 1 year after initiation of nucleos(t)ide analog therapy for chronic hepatitis B.
    Kaneko S; Kurosaki M; Mashiba T; Marusawa H; Kondo M; Kojima Y; Uchida Y; Fujii H; Akahane T; Yagisawa H; Kusakabe A; Kobashi H; Abe T; Yoshida H; Ogawa C; Furuta K; Tamaki N; Tsuji K; Matsushita T; Izumi N;
    J Med Virol; 2023 Jan; 95(1):e28210. PubMed ID: 36222204
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Special issue "The advance of solid tumor research in China": Prediction of Sunitinib efficacy using computed tomography in patients with pancreatic neuroendocrine tumors.
    Chen L; Wang W; Jin K; Yuan B; Tan H; Sun J; Guo Y; Luo Y; Feng ST; Yu X; Chen MH; Chen J
    Int J Cancer; 2023 Jan; 152(1):90-99. PubMed ID: 36111424
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Novel lectin-based chimeric antigen receptors target Gb3-positive tumour cells.
    Meléndez AV; Velasco Cárdenas RM; Lagies S; Strietz J; Siukstaite L; Thomas OS; Tomisch J; Weber W; Kammerer B; Römer W; Minguet S
    Cell Mol Life Sci; 2022 Sep; 79(10):513. PubMed ID: 36097202
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Laparoscopic pancreatic enucleation: cystic lesions and proximity to the Wirsung duct increase postoperative pancreatic fistula.
    Aussilhou B; Ftériche FS; Bouquot M; Lesurtel M; Sauvanet A; Dokmak S
    Surg Endosc; 2023 Jan; 37(1):544-555. PubMed ID: 36002687
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The Effect of HER2 Status on Metaplastic Breast cancer A Propensity Score-Matched Analysis.
    Hu J; Zhang Y; Dong F; Shen J; Chen H; Li L; Huang T
    Front Endocrinol (Lausanne); 2022; 13():874815. PubMed ID: 35928894
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The Effect of Goal-Directed Fluid Administration on Outcomes After pancreatic Surgery.
    Siegel JB; O'Leary R; DeChamplain B; Lancaster WP
    World J Surg; 2022 Nov; 46(11):2760-2768. PubMed ID: 35896759
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Impact of the COVID-19 pandemic on disease stage and treatment for patients with pancreatic adenocarcinoma: A French comprehensive multicentre ambispective observational cohort study (CAPANCOVID).
    Brugel M; Letrillart L; Evrard C; Thierry A; Tougeron D; El Amrani M; Piessen G; Truant S; Turpin A; d'Engremont C; Roth G; Hautefeuille V; Regimbeau JM; Williet N; Schwarz L; Di Fiore F; Borg C; Doussot A; Lambert A; Moulin V; Trelohan H; Bolliet M; Topolscki A; Ayav A; Lopez A; Botsen D; Piardi T; Carlier C; Bouché O
    Eur J Cancer; 2022 May; 166():8-20. PubMed ID: 35259629
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Total neoadjuvant therapy for pancreatic adenocarcinoma increases probability for a complete pathologic response.
    Barrak D; Villano AM; Villafane-Ferriol N; Stockton LG; Hill MV; Deng M; Handorf EA; Reddy SS
    Eur J Surg Oncol; 2022 Jun; 48(6):1356-1361. PubMed ID: 35016837
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A novel staging system and clinical predictive nomogram for more accurate staging and prognosis of malignant pancreatic intraductal papillary mucinous neoplasms: a population-based study.
    Zhang H; Gao C; Chen J; Wu S; Bai J; Yin T
    J Transl Med; 2021 Dec; 19(1):525. PubMed ID: 34952605
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Expression of CD200 and INSM1 in gastrointestinal and pancreatic neuroendocrine neoplasms and its diagnostic values].
    Cao Z; Cen HB; Wei JG; Qin LZ; Liao W; Ao QL
    Zhonghua Bing Li Xue Za Zhi; 2021 Oct; 50(10):1134-1138. PubMed ID: 34619866
    [No Abstract]    [Full Text] [Related]  

  • 20. Distal pancreatectomy with resection of the celiac trunk, right or left hepatic artery without arterial reconstruction (extended DP-CAR).
    Egorov VI; Petrov RV; Amosova EL; Kharazov AF; Petrov KS; Zhurina YA; Kondratyev EV; Zelter PM; Dzigasov SO; Grigorievsky MV
    Khirurgiia (Mosk); 2021; (10):13-28. PubMed ID: 34608776
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.